C-peptide response to glucagon in diabetics with and without complications. 1979

R B Smith, and D A Pyke, and P J Watkins, and C Binder, and O K Faber

Beta cell function has been studied by measurement of C-peptide responses to intravenous glucagon in 11 diabetics with advanced complications and compared with nine long-term diabetics without complications. The majority had no C-peptide responses, but there was evidence of beta cell function in one patient from each group. These observations suggest that some factor other than continuing beta cell function is involved in the complications of insulin-requiring diabetics.

UI MeSH Term Description Entries
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

R B Smith, and D A Pyke, and P J Watkins, and C Binder, and O K Faber
June 1989, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
R B Smith, and D A Pyke, and P J Watkins, and C Binder, and O K Faber
March 1982, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
R B Smith, and D A Pyke, and P J Watkins, and C Binder, and O K Faber
January 1987, Diabetes care,
R B Smith, and D A Pyke, and P J Watkins, and C Binder, and O K Faber
September 1986, British journal of clinical pharmacology,
R B Smith, and D A Pyke, and P J Watkins, and C Binder, and O K Faber
August 1985, Metabolism: clinical and experimental,
R B Smith, and D A Pyke, and P J Watkins, and C Binder, and O K Faber
January 1978, Osaka city medical journal,
R B Smith, and D A Pyke, and P J Watkins, and C Binder, and O K Faber
May 1992, Journal of the Formosan Medical Association = Taiwan yi zhi,
R B Smith, and D A Pyke, and P J Watkins, and C Binder, and O K Faber
January 1985, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
R B Smith, and D A Pyke, and P J Watkins, and C Binder, and O K Faber
December 1981, Diabete & metabolisme,
R B Smith, and D A Pyke, and P J Watkins, and C Binder, and O K Faber
June 1986, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
Copied contents to your clipboard!